Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers.

[1]  M. Thelen,et al.  Hemodynamic effects of monomeric nonionic contrast media in pulmonary angiography in chronic thromboembolic pulmonary hypertension. , 2006, AJR. American journal of roentgenology.

[2]  T. Fleming,et al.  Sildenafil citrate therapy for pulmonary arterial hypertension. , 2005, The New England journal of medicine.

[3]  Vic Hasselblad,et al.  Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. , 2005, JAMA.

[4]  William T. Abraham,et al.  Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness , 2005 .

[5]  M. Singer,et al.  Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial , 2005, The Lancet.

[6]  D. Badesch,et al.  Ambrisentan therapy for pulmonary arterial hypertension. , 2005, Journal of the American College of Cardiology.

[7]  M. Humbert,et al.  Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.

[8]  Monica R. Shah,et al.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness The ESCAPE Trial , 2005 .

[9]  M. Zumberg,et al.  A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. , 2005, Chest.

[10]  Horst Olschewski,et al.  Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. , 2004, European heart journal.

[11]  David S. Lee,et al.  Safety and hemodynamic effects of pulmonary angiography in patients with pulmonary hypertension: 10-year single-center experience. , 2004, AJR. American journal of roentgenology.

[12]  D. Mccrory,et al.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[13]  A. Torbicki,et al.  Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[14]  A. Torbicki,et al.  End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. , 2004, Journal of the American College of Cardiology.

[15]  P. Corris,et al.  Interventional and surgical modalities of treatment for pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[16]  M. Pfisterer,et al.  Selective embolization of a pulmonary artery rupture caused by a Cournand catheter , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  R. Dixon,et al.  Sitaxsentan therapy for pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.

[18]  W. Seeger,et al.  Inhaled iloprost for severe pulmonary hypertension. , 2002, The New England journal of medicine.

[19]  M. Humbert,et al.  Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. , 2002, Journal of the American College of Cardiology.

[20]  S. Rich,et al.  Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.

[21]  M. Rubenfire,et al.  Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. , 2002, American journal of respiratory and critical care medicine.

[22]  G. Castro.  [Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study]. , 2001, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[23]  F Golliot,et al.  Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. , 2001, JAMA.

[24]  P J Scanlon,et al.  ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and , 1999, Circulation.

[25]  M. Thelen,et al.  Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension. , 1996, Circulation.

[26]  W. Seeger,et al.  Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension , 1996, Annals of Internal Medicine.

[27]  G. E. Newman,et al.  Prospective evaluation of pulmonary artery pressures during pulmonary angiography performed with low-osmolar nonionic contrast media. , 1996, Journal of vascular and interventional radiology : JVIR.

[28]  W. Auger,et al.  Chronic major-vessel thromboembolic pulmonary hypertension. , 1990, Circulation.

[29]  K. Peterson,et al.  Pulmonary angiography in severe chronic pulmonary hypertension. , 1987, Annals of internal medicine.

[30]  E H Bergofsky,et al.  Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.

[31]  V. Fuster,et al.  Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.

[32]  C. Higgins,et al.  Effects of contrast media on pulmonary hemodynamics: comparison of ionic and non-ionic agents. , 1983, Radiology.

[33]  S. R. Mills,et al.  The incidence, etiologies, and avoidance of complications of pulmonary angiography in a large series. , 1980, Radiology.

[34]  J. Messer,et al.  Clinical Conference in Pulmonary DiseasePrimary Pulmonary Hypertension: A Fatality during Pulmonary Angiography: Clinical Conference from Boston University School of Medicine , 1973 .

[35]  H. Watson.  SEVERE PULMONARY HYPERTENSIVE EPISODES FOLLOWING ANGIOCARDIOGRAPHY WITH SODIUM METRIZOATE. , 1964, Lancet.

[36]  G. Gensini,et al.  Primary pulmonary hypertension with death during right heart catheterization. A case report and a survey of reported fatalities. , 1959, The American journal of cardiology.

[37]  W. Seeger,et al.  A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. , 2000, Journal of the American College of Cardiology.

[38]  G. E. Newman,et al.  Pulmonary angiography performed with iopamidol: complications in 1,434 patients. , 1996, Radiology.

[39]  G. E. Newman,et al.  Pulmonary arteriography in the high-risk patient. , 1987, Radiology.